-
公开(公告)号:US20250043278A1
公开(公告)日:2025-02-06
申请号:US18928324
申请日:2024-10-28
Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
Inventor: Tamir TULLER , Ofek SCHNITZER , Hadas ZUR , Zohar ZAFRIR
IPC: C12N15/11 , C12N9/22 , C12N15/67 , C12Q1/6886
Abstract: The present invention is directed to a method for treating cancer in a subject determined as having the presence of a G600>A substitution, a C601>T substitution, or both, in the B cell lymphoma 2 (BCL2) gene of a cell.